Quince Therapeutics, Inc. (QNCX)
31.32
+0.77
(+2.52%)
USD |
NASDAQ |
Sep 04, 16:00
31.18
-0.14
(-0.43%)
After-Hours: 20:00
Quince Therapeutics EPS Diluted (Quarterly) : -12.31 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.31 |
| March 31, 2026 | 78.15 |
| December 31, 2025 | -141.62 |
| September 30, 2025 | -49.83 |
| June 30, 2025 | -68.75 |
| March 31, 2025 | -0.342 |
| December 31, 2024 | -56.78 |
| September 30, 2024 | -0.1272 |
| June 30, 2024 | -0.6434 |
| March 31, 2024 | -0.2592 |
| December 31, 2023 | -0.2171 |
| September 30, 2023 | -0.1483 |
| June 30, 2023 | -0.136 |
| March 31, 2023 | -0.3418 |
| December 31, 2022 | -0.1531 |
| September 30, 2022 | -0.2224 |
| Date | Value |
|---|---|
| June 30, 2022 | -0.5102 |
| March 31, 2022 | -0.7182 |
| December 31, 2021 | -0.7812 |
| September 30, 2021 | -0.7292 |
| June 30, 2021 | -0.7352 |
| March 31, 2021 | -0.7811 |
| December 31, 2020 | -0.6958 |
| September 30, 2020 | -0.7293 |
| June 30, 2020 | -0.5982 |
| March 31, 2020 | -0.6078 |
| December 31, 2019 | -0.4607 |
| September 30, 2019 | -0.3673 |
| June 30, 2019 | -0.5718 |
| March 31, 2019 | -0.2116 |
| June 30, 2018 | -23.16 |
| March 31, 2018 | -0.1258 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0749 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -75.49M |
| Total Expenses (Quarterly) | 75.49M |
| Enterprise Value | 59.69M |
| Earnings Yield | -401.0% |
| Normalized Earnings Yield | -386.71 |